KalVista Pharmaceuticals, Inc. (KALV)
15.94
-0.86
(-5.12%)
USD |
NASDAQ |
Jan 12, 12:19
KalVista Pharmaceuticals Accounts Payable (Quarterly): 8.074M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 5.567M |
| Silvergate Capital Corp. | -- |
| Perspective Therapeutics, Inc. | 12.95M |
| Electromed, Inc. | 3.138M |
| InfuSystem Holdings, Inc. | 10.02M |